Exploiting ultrasound-mediated effects in delivering targeted, site-specific cancer therapy

Cancer Letters

Volumn 296, Issue 2, 2010, Pages 133-143

  Nomikou, Nikolitsa ^a,b   McHale, Anthony P ^a  

^a UNIVERSITY OF ULSTER   (United Kingdom)

^b Sonidel Ltd   (Ireland)

Author keywords

Chemotherapy; Gene; Microbubbles; Sonoporation; Ultrasound

Indexed keywords

BLEOMYCIN; CAMPTOTHECIN; CYTARABINE; CYTOKINE; DOXORUBICIN; ECHO CONTRAST MEDIUM; GANCICLOVIR; INTERLEUKIN 12; LIPOSOME; PACLITAXEL; PERFLUTREN; SONOVUE; THYMIDINE KINASE; TRACER; VIRUS VECTOR;

ANTINEOPLASTIC ACTIVITY; CANCER CHEMOTHERAPY; COLON CANCER; CONTRAST ENHANCEMENT; DRUG DISTRIBUTION; DRUG EFFICACY; DRUG PENETRATION; DRUG POTENTIATION; DRUG SPECIFICITY; DRUG TARGETING; FIBROSARCOMA; HUMAN; LIPOSOMAL GENE DELIVERY SYSTEM; LIVER CELL CARCINOMA; LIVER METASTASIS; MICROBUBBLE; NONHUMAN; OVARY CANCER; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; SHORT SURVEY; SUICIDE GENE THERAPY; TUMOR VASCULARIZATION; ULTRASOUND THERAPY; VIRAL GENE DELIVERY SYSTEM;

EID: 77955282033     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2010.06.002     Document Type: Review

References (81)

1. Baker J.P. The history of sonographers. J. Ultrasound Med. 2005, 24:1-14.
2. Schroeder A., Kost J., Barenholz Y. Ultrasound, liposomes and drug delivery: principles for using ultrasound to control release of drugs from liposomes. Chem. Phys. Lipids 2009, 162:1-16.
3. ter Haar G. Therapeutic applications of ultrasound. Prog. Biophys. Mol. Biol. 2007, 93:111-129.
4. Kremkau F.W. Cancer therapy with ultrasound: a historical review. J. Clin. Ultrasound 1979, 7:287-300.
5. ter Haar G. High intensity focussed ultrasound: a surgical technique for the treatment of discrete liver tumours. Med. Biol. 1989, 34:1743-1750.
6. Jolesz F.A. MRI-guided focused ultrasound surgery. Annu. Rev. Med. 2009, 60:417-430.
7. Hahn G.M. Does the mode of heat induction modify drug anti-tumour effects?. Br. J. Cancer 1982, 45:238-242. (Suppl. V).
8. Feril L.B., Kondo T., Umera S., Tachibana K., Manalo A.H., Riesz P. Sound waves and antineoplastic drugs: the possibility of an enhanced combined anticancer therapy. J. Med. Ultrason. 2002, 29:173-187.
9. Harrison G.H., Balcer-Kubiczek E.K., Gutierrez P.L. In vitro mechanisms of chemopotentiation by tone-burst ultrasound. Ultrasound Med. Biol. 1996, 11:355-362.
10. Loverock P., ter Haar G., Ormerod M.G., Imrie P.R. The effect of ultrasound on the cytotoxicity of adriamycin. Br. J. Rad. 1990, 63:542-546.
11. G.M. Hahn, A.H. Saad, D.B. Tata, Ultrasound-enhanced cytotoxicity of doxorubicin against normal and multidrug resistant cells, in: 41st Annual Meeting of the Radiation Research Society, 1993 (Abstract S-05-2).
12. Li Y.S., Reid C.N., McHale A.P. Enhancing ultrasound-mediated cell membrane permeabilisation (sonoporation) using a high frequency pulse regime and implications for ultrasound-aided cancer chemotherapy. Cancer Lett. 2008, 266:156-162.
13. Umemura S., Yumita N., Okano Y., Kaneuchi M., Magario N., Ishizaki M., Shimizu K., Sano Y., Umemura K., Nishigaki R. Sonodynamically-induced in vitro cell damage enhanced by adriamycin. Cancer Lett. 1997, 121:195-201.
14. Yoshida T., Kondo T., Ogawa R., Feril L.B., Zhao Q.L., Watanabe A., Tsukada K. Combination of doxorubicin and low-intensity ultrasound causes a synergistic enhancement in cell killing and an additive enhancement in apoptosis induction in human lymphoma U937 cells. Cancer Chemother. Pharmacol. 2008, 61:559-567.
15. Kuroki M., Hachimine K., Abe H., Shibaquchi H., Juroki M., Maekawa S., Yanagisawa J., Kinugasa T., Tanaka T., Yamashita Y. Sonodynamic therapy of cancer using novel sonosensitizers. Anticancer Res. 2007, 27:3671-3677.
16. Larkin J.O., Casey G.D., Tangney M., Cashman J., Collins G.G., Soden D.M., O'Sullivan G.C. Effective tumor treatment using optimised ultrasound-mediated delivery of bleomycin. Anticancer Res. 2008, 34:406-413.
17. Mir L.M., Morsli N., Garbay J.R., Billard V., Robert C. Electrochemotherapy: a new treatment of solid tumors. J. Exp. Clin. Cancer Res. 2003, 22:145-148.
18. Sadadcharam M., Soden D.M., O'Sullivan G.C. Electrochemotherapy: an emerging cancer treatment. Int. J. Hyperthermia 2008, 24:263-273.
19. Nomikou N., Li Y.S., McHale A.P. Ultrasound-enhanced drug dispersion through solid tumours and its possible role in aiding ultrasound-targeted cancer chemotherapy. Cancer Lett. 2010, 288:94-98.
20. Fanciullino R., Ciccolini J. Liposome-encapsulated anticancer drugs: still waiting for the magic bullet?. Curr. Med. Chem. 2009, 16:4361-4371.
21. Peyrl A., Sauermann R., Traunmueller F., Azizi A.A., Gruber-Olipitz M., Gupper A., Slavc I. Pharmacokinetics and safety of intrathecal liposomal cytarabine in children aged 3 years. Clin. Pharmacokinet. 2009, 48:265-271.
22. Malam Y., Loizidou M., Seifalian A.M. Liposomes and nanoparticles: nanosized vehicles for drug delivery in cancer. Trends Pharmacol. Sci. 2009, 30:592-599.
23. Huwyler J., Drewe J., Krahenbuhl S. Tumor targeting using liposomal antineoplastic drugs. Int. J. Nanomed. 2008, 3:21-29.
24. Wu N.Z., Da D., Rudoll T.L., Needham D., Whorton A.R., Dewhirst M.W. Increased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumour tissue. Caner Res. 1993, 53:3765-3770.
25. Myhr G., Moan J. Synergistic and tumour selective effects of chemotherapy and ultrasound treatment. Cancer Lett. 2006, 232:206-213.
26. Schroeder A., Honen R., Turjeman K., Gabizon A., Kost J., Barenholz Y. Ultrasound triggered release of cisplatin from liposomes in murine tumors. J. Controlled Release 2009, 137:63-68.
27. Husseini G.A., Pitt W.G. The use of ultrasound and micelles in cancer treatment. J. Nanosci. Nanotechnol. 2008, 8:2205-2215.
28. Jang H.J., Yu H., Kim T.K. Contrast-enhanced ultrasound in the detection and characterisation of liver tumors. Cancer Imaging 2009, 6:96-103.
29. Hwang M., Niermann K.J., Lyshchik A., Fleischer A.C. Sonographic assessment of tumor response: from in vivo models to clinical applications. Ultrasound Q. 2009, 25:175-183.
30. Newman C.M.W., Bettinger T. Gene therapy progress and prospects: ultrasound for gene transfer. Gene Ther. 2007, 14:465-475.
31. Yanagisawa K., Moriyasu F., Miyahara T., Yuki M., Iijima H. Phagocytosis of ultrasound contrast agent microbubbles by Kupffer cells. Ultrasound Med. Biol. 2007, 33:318-325.
32. Yu T., Hu D., Microbubbles C.Xu. Microbubbles improve the ablation efficiency of extracorporeal high intensity focused ultrasound against kidney tissues. World J. Urol. 2008, 26:631-636.
33. Hanajiri K., Maruyama T., Kaneko Y., Mitsui H., Watanabe S., Sata M., Nagai R., Kashima T., Shibahara J., Omata M., Matsumoto Y. Microbubble-induced increase in ablation of liver tumors by high intensity focussed ultrasound. Hepatol. Res. 2006, 36:308-314.
34. Coussios C.C., Farny C.H., ter Haar G., Roy R.A. Role of acoustic cavitation in the delivery and monitoring of cancer treatment by high-intensity focussed ultrasound (HIFU). Int. J. Hyperthermia 2007, 23:105-120.
35. Prat F., Vhapelon J.Y., El Fadill F.A., Theilleral Y., Ponchon T., Cathignoll D. In vivo effects of cavitation alone or in combination with chemotherapy in a peritoneal carcinomatosis in rat. Br. J. Cancer 1993, 68:13-17.
36. Blomley M.J.K., Cooke J.C., Unger E.C., Monaghan M.J., Cosgrove D.O. Microbubble contrast agents: a new era in ultrasound. BMJ 2001, 322:1222-1225.
37. Unger E.C., Hersh E., Vannan M., Matsunaga T.O., McCreery T. Local drug and gene delivery through microbubbles. Prog. Cardiovasc. Dis. 2001, 44:45-54.
38. Sonoda S., Tachibana K., Uchino E., Yamashita T., Sakoda K., Sonoda K.H., Hisatomi T., Izumi Y., Sakamoto T. Inhibition of melanoma by ultrasound-microbubble-aided drug delivery suggests membrane permeabilisation. Cancer Biol. Ther. 2007, 6:1276-1283.
39. Iwanaga k., Tominaga K., Yamamoto K., Habu M., Maeda H., Akifusa S., Tsujisawa T., Okinaga T., Fukuda J., Nishihara T. Local delivery system of cytotoxic agents to tumors by focused sonoporation. Cancer Gene Ther. 2007, 14:354-363.
40. Tinkov S., Winter G., Coester C., Bekeredjian R. New Doxorubicin-loaded phospholipid microbubbles for targeted tumor therapy: Part 1 - formulation development and in vitro characterisation. J. Controlled Release 2010, 143:143-150.
41. Kheirolomoom A., Dayton P.A., Lum A.F.H., Little E., Paoli E.E., Zheng H., Ferrara K.W. Acoustically-active microbubbles conjugated to liposomes: characterization of a proposed drug delivery vehicle. J. Controlled Release 2007, 118:275-284.
42. Lentaker I., Geers B., Demeester J., De Smedt S.C., Sanders N.N. Design and evaluation of doxorubicin-containing microbubbles for ultrasound-triggered doxorubicin delivery: cytotoxicity and mechanisms involved. Mol. Ther. 2010, 18:101-108.
43. Rapoport N.Y., Kennedy A.M., Shea J.E., Scaife C.L., Nam K.-H. Controlled and targeted tumor chemotherapy by ultrasound-activated nanoemulsions/microbubbles. J. Controlled Release 2009, 138:268-276.
44. Bull J.L. The application of microbubbles for targeted drug delivery. Expert Opin. Drug Deliv. 2007, 4:475-493.
45. Rychak J.J., Lindner J.R., Ley K., Klibanov A.L. Deformable gas-filled microbubbles targeted to P-selectin. J. Controlled Release 2006, 114:288-299.
46. Bian A.-N., Gao Y.-H., Tan K.-B., Liu P., Zeng G.-J., Zhang X., Liu Z. Preparation of human hepatocellular carcinoma-targeted liposome microbubbles and their immunological properties. World J. Gastroenterol. 2004, 10:3424-3427.
47. Lathia J.D., Leodore L., Wheatley M.A. Polymeric contrast agent with targeting potential. Ultrasonics 2004, 42:763-768.
48. Weller G.E.R., Wong M.K.K., Modzelewski R.A., Lu E., Klibanov A.L., Wagner W.R., Villanueva F.S. Ultrasonic imaging of tumor angiogenesis using contrast microbubbles targeted via the tumour-binding peptide arginine-arginine-leucine. Cancer Res. 2005, 65:533-539.
49. Li X., Jin Q., Chen T., Zhang B., Zheng R., Wang Z., Zheng H. LyP-1 ultrasonic microbubbles targeting to cancer cell as tumor bioacoustics markers or drug carriers: targeting efficiency evaluation in microfluidic channels. Conf. Proc. IEEE Eng. Med. Biol. 2009, 2009:463-464.
50. Simberg D., Mattrey R. Targeting perfluorocarbon microbubbles to selective populations of circulating blood cells. J. Drug Targeting 2009, 17:392-398.
51. Bouuaert C.C., Chalmers R.A. Gene therapy vectors: the prospects and potentials of the cut-and-paste transposons. Genetica 2009, 135:473-484.
52. Bushman F.D. Retroviral integration and human gene therapy. J. Clin. Invest. 2007, 117:2083-2086.
53. Howard C.M., Forsberg F., Minimo C., Liu Jl-Bin, Merton D.A., Claudio P.P. Ultrasound guided site specific gene delivery system using adenoviral vectors and commercial ultrasound contrast agents. J. Cell. Physiol. 2006, 209:413-421.
54. Feril L.B., Ogawa R., Tachibana K., Kondo T. Optimised ultrasound-mediated gene transfection in cancer cells. Cancer Sci. 2006, 97:1111-1114.
55. 2 cells. Biochem. Biophys. Res. Commun. 2006, 343:470-474.
56. Manome Y., Nakamura M., Ohno T., Furuhata H. Ultrasound facilitates transduction of naked plasmid DNA into colon carcinoma cells in vitro and in vivo. Human Gene Ther. 2000, 11:1521-1528.
57. Watanabe A., Otake R., Nozaki T., Morii A., Ogawa T., Fujimoto S., Nakamura S., Fuse H., Kondo T. Effects of microbubbles on ultrasound-mediated gene transfer in human prostate cancer PC3 cells: Comparison among Levovist, YM454 and MRX-815H. Cancer Lett. 2008, 265:107-112.
58. Wang J.-F., Wang J.-B., Zhang C.-M., Liu L., Wu C.-J. Ultrasound-mediated microbubble enhances gene transfection in pancreatic cancer cells. Adv. Ther. 2008, 25:412-421.
59. Luo Y.K., Zhao Y.Z., Lu C.T., Tang J., Li X.K. Application of ultrasonic gas-filled liposomes in enhancing transfer for breast cancer-related antisense olidonucleotides: an experimental study. J. Liposome Res. 2008, 18:341-351.
60. Li Y.S., Davidson E., Reid C.N., McHale A.P. Optimising ultrasound-mediated gene transfer (sonoporation) in vitro and prolonged expression of a transgene in vivo: potential applications for gene therapy of cancer. Cancer Lett. 2009, 273:62-69.
61. Aoi A., Watanabe Y., Mori S., Takahashi M., Vassaux G., Kodama T. Herpes simplex virus thymidine kinase-mediated suicide gene therapy using nano-microbubbles and ultrasound. Ultrasound Med. Biol. 2008, 34:425-434.
62. Mehier-umbert S., Yan F., Frinking P., Schneider M., Guy R.H., Bettinger T. Ultrasound-mediated gene delivery: influence of contrast agent on transfection. Bioconjugate Chem. 2007, 18:652-662.
63. Wells D.J. Electroporation and ultrasound enhanced non-viral gene delivery in vitro and in vivo. Cell. Biol. Toxicol. 2010, 26:21-28.
64. Christiansen J.P., French B.A., Klibanov A.L., Kaul S., Lindner J.R. Targeted tissue transfection with ultrasound destruction of plasmid-bearing cationic microbubbles. Ultrasound Med. Biol. 2003, 29:1759-1767.
65. Lentacker I., De Geest B.G., Vandenbroucke R.E., Peeters L., Demeester J., De Smedt S.C., Sanders N.N. Ultrasound-responsive polymer-coated microbubbles that bind and protect DNA. Langmuir 2007, 22:7273-7278.
66. Frenkel P.A., Chen S., Thai T., Shohet R.V., Grayburn P.A. DNA-loaded albumin microbubbles enhance ultrasound-mediated transfection in vitro. Ultrasound Med. Biol. 2002, 28:817-822.
67. Hauff P., Seemann S., Reszka R., Schultze-Mosgau M., Reinhardt M., Buzasi T., Plath T., Rosewicz S., Schirner M. Evaluation of gas-filled microparticles and sonoporation as gene delivery system: feasibility study in rodent tumor models. Radiology 2005, 236:572-578.
68. Tsai K.-C., Liao Z.-K., Yang S.-J., Lin W.-L., Shieh M.-J., Hwang L.-H., Chen W.-S. Differences in gene expression between sonoporation in tumor and in muscle. J. Gene Med. 2009, 11:933-940.
69. Sakakimi Y., Hayashi S., Yagi Y., Hayakawa A., Tachibana K., Nakao A. Gene therapy for hepatocellular carcinoma using sonoporation enhanced by contrast agents. Cancer Gene Ther. 2005, 12:884-889.
70. Suziki R., Namai E., Oda Y., Nishiie N., Otake S., Koshima R., Hirata K., Taira Y., Utoguchi N., Neghishi Y., Nakagawa S., Maruyama K. Cancer gene therapy by IL-12 gene delivery using liposomal bubbles and tumoral ultrasound exposure. J. Controlled Release 2010, 142:245-250.
71. Azuma H., Tomita N., Sakamoto T., Kiyama S., Inamoto T., Takahara K., Kotake Y., Segawa N., Morishita R., Takahara S., Hayasaki H., Otsuki Y., Horie S., Tanigawa N., Katsuoka Y. Marked regression of liver metastasis by combined therapy of ultrasound-mediated NFkB-decoy transfer and transportal injection of paclitaxel, in mouse. Int. J. Cancer 2008, 122:1645-1656.
72. Haag P., Frauscher F., Gradl J., Seitz A., Schafer G., Lindner J.R., Klibanov A.L., Bartsch G., Klocker H., Eder I.E. Microbubble-enhanced ultrasound to deliver an antisense oligodeoxynucleotide targeting the human androgen receptor into prostate tumours. J. Steroid Biochem. Mol. Biol. 2006, 102:103-113.
73. Tang W., Liu Q., Wang X., Zhang J., Wang P., Mi N. Ultrasound exposure in the presence of hematoporphyrin induced loss of membrane integral proteins and inactivity of cell proliferation associated enzymes in sarcoma 180 cells in vitro. Ultrason. Sonochem. 2008, 15:747-754.
74. Tomankova K., Kolarova H., Kolar P., Kejlova K., Jirova D. Study of cytotoxic effect of photodynamically and sonodynamically activated sensitizers in vitro. Toxicol. in Vitro 2009, 23:1465-1471.
75. Wang X., Lewis T.J., Mitchell D. The tumoricidal effect of sonodynamic therapy (SDT) on S-180 sarcoma in mice. Integrative Cancer Ther. 2008, 7:96-102.
76. Rollan Haro A.M., Smyth A., Hughes P., Reid C.N., McHale A.P. Electro-sensitisation of mammalian cells and tissues to ultrasound: a novel tumour treatment modality. Cancer Lett. 2005, 10:49-55.
77. Larkin J., Soden D., Collins C., Tangney M., Preston J.M., Russell L.J., McHale A.P., Dunne C., O'Sullivan G.C. Combined electric field and ultrasound therapy as a novel anti-tumour treatment. Eur. J. Cancer 2005, 41:1339-1348.
78. Bekeredjian R., Kroll R.D., Fein E., Tinkov S., Coester C., Winter G., Katus H.A., Kulaksiz H. Ultrasound targeted microbubble destruction increases capillary permeability in hepatomas. Ultrasound Med. Biol. 2007, 33:1592-1598.
79. Yang F.-Y., Fu W.-M., Yang R.-S., Liou H.-C., Kang K.-H., Lin W.-L. Qualitative evaluation of focused ultrasound with a contrast agent on blood-brain barrier disruption. Ultrasound Med. Biol. 2007, 33:1421-1427.
80. Frinkley Bing K., Howles G.P., Qi Y., Palmeri M.L., Nightingale K.R. Blood-brain barrier (BBB) disruption using a diagnostic ultrasound scanner and definity in mice. Ultrasound Med. Biol. 2009, 35:1298-1308.
81. Zhang Z., Xai C., Xue Y., Liu Y. Synergistic effect of low-frequency ultrasound and low-dose bradykinin on increasing permeability of the blood tumor barrier by opening tight junction. J. Neurosci. Res. 2009, 87:2282-2289.